Brainomix vs ScreenPoint Transpara

Transpara is for breast screening. It supports reading of 2D FFDM and 3D tomosynthesis mammograms, sits behind eight 510(k) records with the latest, K260898, dated August 2026, and the vendor calls it vendor agnostic. Breast imaging centers and screening programs are its users, while Brainomix goes to hospital stroke services. The MASAI trial ran in Swedish screening, and the vendor reports 80.5% sensitivity against 73.8% for standard double reading across more than 105,000 women. Its page shows a 29% rise in cancers detected and a 44% workload cut, and those come from different analyses.

Hospitals running stroke pathways use Brainomix. It can run on a dedicated server, a virtual server or a secure cloud, and the trust page says patient data is stored inside the hospital. The vendor cites a Lancet Digital Health paper reporting a 100% rise in thrombectomy rates across 107 hospitals and 452,000 patients.